Apatient-specific individual risk score is evaluated based on an original algorithm thatcombines the expression level of three RNAs (PCA3 noncoding RNA, ERG mRNA, and SPDEFmRNA), which are correlated with clinically significant prostate cancer, detected directlyin urinary EV RNAs[118]. Here, PCA3 is linked to prostate cancer.